Cargando…

Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma

PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2))...

Descripción completa

Detalles Bibliográficos
Autores principales: Mürtz, Petra, Penner, Arndt-Hendrik, Pfeiffer, Anne-Kristina, Sprinkart, Alois M, Pieper, Claus C, König, Roy, Block, Wolfgang, Schild, Hans H, Willinek, Winfried A, Kukuk, Guido M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079699/
https://www.ncbi.nlm.nih.gov/pubmed/27799790
http://dx.doi.org/10.2147/OTT.S113909
_version_ 1782462586909884416
author Mürtz, Petra
Penner, Arndt-Hendrik
Pfeiffer, Anne-Kristina
Sprinkart, Alois M
Pieper, Claus C
König, Roy
Block, Wolfgang
Schild, Hans H
Willinek, Winfried A
Kukuk, Guido M
author_facet Mürtz, Petra
Penner, Arndt-Hendrik
Pfeiffer, Anne-Kristina
Sprinkart, Alois M
Pieper, Claus C
König, Roy
Block, Wolfgang
Schild, Hans H
Willinek, Winfried A
Kukuk, Guido M
author_sort Mürtz, Petra
collection PubMed
description PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2)) was retrospectively analyzed in 25 patients who underwent magnetic resonance imaging at 1.5 T before and 6 weeks following the first cycle of transarterial chemoembolization therapy, transarterial ethanol-lipiodol embolization therapy, and transarterial radioembolization therapy. In addition to the determination of apparent diffusion coefficient, ADC(0,800), an estimation of the diffusion coefficient, D′, and the perfusion fraction, f′, was performed by using a simplified IVIM approach. Parameters were analyzed voxel-wise. Tumor response was assessed in a central slice by using a region of interest (ROI) covering the whole tumor. HCCs were categorized into two groups, responders and nonresponders, according to tumor size changes on first and second follow ups (if available) and changes of contrast-enhanced region on the first follow up. RESULTS: In total, 31 HCCs were analyzed: 17 lesions were assigned to responders and 14 were to nonresponders. In responders, ADC(0,800) and D′ were increased after therapy by ~30% (P=0.00004) and ~42% (P=0.00001), respectively, whereas f′ was decreased by ~37% (P=0.00094). No significant changes were found in nonresponders. Responders and nonresponders were better differentiated by changes in D′ than by changes in ADC(0,800) (area under the curve =0.878 vs 0.819 or 0.714, respectively). CONCLUSION: In patients with HCCs undergoing embolization therapy, diffusion changes were better reflected by D′ than by conventional ADC(0,800), which is influenced by counteracting perfusion changes as assessed by f′.
format Online
Article
Text
id pubmed-5079699
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-50796992016-10-31 Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma Mürtz, Petra Penner, Arndt-Hendrik Pfeiffer, Anne-Kristina Sprinkart, Alois M Pieper, Claus C König, Roy Block, Wolfgang Schild, Hans H Willinek, Winfried A Kukuk, Guido M Onco Targets Ther Original Research PURPOSE: The aim of this study was to evaluate an intravoxel incoherent motion (IVIM) model–based analysis of diffusion-weighted imaging (DWI) for assessing the response of hepatocellular carcinoma (HCC) to locoregional therapy. PATIENTS AND METHODS: Respiratory-gated DWI (b=0, 50, and 800 s/mm(2)) was retrospectively analyzed in 25 patients who underwent magnetic resonance imaging at 1.5 T before and 6 weeks following the first cycle of transarterial chemoembolization therapy, transarterial ethanol-lipiodol embolization therapy, and transarterial radioembolization therapy. In addition to the determination of apparent diffusion coefficient, ADC(0,800), an estimation of the diffusion coefficient, D′, and the perfusion fraction, f′, was performed by using a simplified IVIM approach. Parameters were analyzed voxel-wise. Tumor response was assessed in a central slice by using a region of interest (ROI) covering the whole tumor. HCCs were categorized into two groups, responders and nonresponders, according to tumor size changes on first and second follow ups (if available) and changes of contrast-enhanced region on the first follow up. RESULTS: In total, 31 HCCs were analyzed: 17 lesions were assigned to responders and 14 were to nonresponders. In responders, ADC(0,800) and D′ were increased after therapy by ~30% (P=0.00004) and ~42% (P=0.00001), respectively, whereas f′ was decreased by ~37% (P=0.00094). No significant changes were found in nonresponders. Responders and nonresponders were better differentiated by changes in D′ than by changes in ADC(0,800) (area under the curve =0.878 vs 0.819 or 0.714, respectively). CONCLUSION: In patients with HCCs undergoing embolization therapy, diffusion changes were better reflected by D′ than by conventional ADC(0,800), which is influenced by counteracting perfusion changes as assessed by f′. Dove Medical Press 2016-10-19 /pmc/articles/PMC5079699/ /pubmed/27799790 http://dx.doi.org/10.2147/OTT.S113909 Text en © 2016 Mürtz et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mürtz, Petra
Penner, Arndt-Hendrik
Pfeiffer, Anne-Kristina
Sprinkart, Alois M
Pieper, Claus C
König, Roy
Block, Wolfgang
Schild, Hans H
Willinek, Winfried A
Kukuk, Guido M
Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title_full Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title_fullStr Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title_full_unstemmed Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title_short Intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
title_sort intravoxel incoherent motion model–based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079699/
https://www.ncbi.nlm.nih.gov/pubmed/27799790
http://dx.doi.org/10.2147/OTT.S113909
work_keys_str_mv AT murtzpetra intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT pennerarndthendrik intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT pfeifferannekristina intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT sprinkartaloism intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT pieperclausc intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT konigroy intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT blockwolfgang intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT schildhansh intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT willinekwinfrieda intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma
AT kukukguidom intravoxelincoherentmotionmodelbasedanalysisofdiffusionweightedmagneticresonanceimagingwith3bvaluesforresponseassessmentinlocoregionaltherapyofhepatocellularcarcinoma